23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Focus
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement

Gubra CEO steps down with immediate effect

Shortly after presenting a new 2030 strategy, Danish biotech company Gubra has replaced its CEO.
Advertisement

The board of directors has appointed two new co-CEOs to replace Markus Rohrwild, who is stepping down as CEO with immediate effect, just over a year after being appointed.

The current Chief Financial Officer, Kristian Borbos, and Head of Gubra Ventures & Business Development, Zoë Johnsen, will take on the co-CEO roles in addition to their current positions.

Advertisement Advertisement
BREAKING
{{ article.headline }}
0.063|